000			01993 a2200517 4500
005			20250514201807.0
264		0	_c20041202
008			200412s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.2004.03.213 _2doi
040			_aNLM _beng _cNLM
100	1		_aLyman, Gary H
245	0	0	_aIncidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cNov 2004
300			_a4302-11 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Murine-Derived
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aChi-Square Distribution
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aLogistic Models
650	0	4	_aLymphoma, Non-Hodgkin _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMitoxantrone _xadministration & dosage
650	0	4	_aPrednisolone _xadministration & dosage
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aRituximab
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States _xepidemiology
650	0	4	_aVincristine _xadministration & dosage
700	1		_aDale, David C
700	1		_aFriedberg, Jonathan
700	1		_aCrawford, Jeffrey
700	1		_aFisher, Richard I
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 22 _gno. 21 _gp. 4302-11
856	4	0	_uhttps://doi.org/10.1200/JCO.2004.03.213 _zAvailable from publisher's website
999			_c15074897 _d15074897